Related Experiment Videos
Muscle protein turnover in uremia
Kidney International. Supplement
|December 1, 1983
Summary
Uremia disrupts muscle protein turnover due to errors in measuring synthesis and degradation. In vitro methods with labeled amino acids offer more reliable insights into muscle protein changes in uremia.
Area of Science:
- Nephrology
- Muscle Physiology
- Biochemistry
Background:
- Uremia is associated with abnormal muscle protein stores, impacting overall health.
- Current in vivo methods for assessing muscle protein turnover in uremia are prone to significant errors.
- Understanding these errors is crucial for accurate assessment of muscle wasting in kidney disease.
Purpose of the Study:
- To critically evaluate the methodologies for measuring muscle protein synthesis and degradation in uremia.
- To identify potential sources of error in existing in vivo techniques.
- To highlight the advantages of in vitro approaches for studying muscle protein turnover in uremic conditions.
Main Methods:
- Review of existing literature on in vivo and in vitro techniques for measuring protein turnover.
- Analysis of factors affecting amino acid kinetics and precursor pool measurements in uremia.
- Discussion of the limitations of 3-methylhistidine as a marker for muscle protein degradation.
Main Results:
- In vivo measurements are confounded by incomplete amino acid equilibration and impaired renal clearance of markers.
- Infusion techniques for degradation lack tissue specificity.
- In vitro studies using radiolabeled amino acids provide more reliable estimates of muscle protein synthesis and degradation.
Conclusions:
- Existing in vivo methods for assessing muscle protein turnover in uremia are unreliable.
- In vitro techniques are recommended for more accurate quantification of muscle protein synthesis and degradation.
- Further research should investigate factors like insulin resistance and fasting adaptation in uremic muscle protein metabolism.